• Dissecting ampC/ampD-Driven Ceftolozane Resistance in P. aer

  2026-07-18

  This study uses semi-mechanistic PK/PD modeling to unravel how specific ampC and ampD mutations drive adaptive and acquired resistance to ceftolozane-tazobactam in Pseudomonas aeruginosa. These findings clarify mutation-specific impacts on drug susceptibility, informing both experimental design and clinical resistance management.

• Veratridine in Excitotoxicity Assays: Precision Tools for So

  2026-07-17

  Explore how Veratridine, a voltage-gated sodium channel opener, enables advanced excitotoxicity studies and sodium channel dynamics research. This article uniquely dissects assay design, mechanistic specificity, and the practical implications of recent scientific breakthroughs.

• PGF2α/PTGFR and HIF-1α in Endometrial Breakdown Regulation

  2026-07-17

  This study demonstrates the essential role of prostaglandin F2α (PGF2α) signaling via its receptor PTGFR, under HIF-1α regulation, in driving endometrial breakdown and vascular dynamics during menstruation in a mouse model. The work provides mechanistic insight into how selective FP receptor antagonists such as AL-8810 can be used to dissect these processes, advancing research in reproductive and vascular biology.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Insig

  2026-07-16

  The reference study provides compelling evidence that moesin (MSN), a membrane-cytoskeleton linker protein, is significantly upregulated in both septic patients and animal models, correlating with disease severity. By elucidating MSN's involvement in endothelial dysfunction via the Rock1/MLC and NF-κB signaling axes, this work establishes MSN as a promising biomarker for monitoring endothelial injury in sepsis and offers practical experimental models for translational research.

• Phenytoin in Sodium Channel Modulation: Protocols & Pitfalls

  2026-07-16

  Leverage Phenytoin (5,5-diphenylimidazolidine-2,4-dione) for high-fidelity sodium channel and enzyme inhibition research. This guide delivers actionable workflow improvements, nuanced troubleshooting, and practical recommendations drawn from recent literature and APExBIO's high-purity offering.

• Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)ben

  2026-07-15

  Discover how Haloprogin enables high-precision antifungal and Gram-positive bacterial assays. This article explores the compound's unique mechanistic profile and provides practical guidance for researchers optimizing in vitro and in vivo protocols.

• Live-Dead Cell Staining Kit: Optimizing Cell Viability Assay

  2026-07-15

  The Live-Dead Cell Staining Kit leverages Calcein-AM and Propidium Iodide dual staining for precise, quantitative cell viability assessment. Discover advanced workflow enhancements, troubleshooting strategies, and real-world applications that set this kit apart for fluorescence microscopy and flow cytometry.

• Ridaforolimus (Deforolimus): Potent Selective mTOR Inhibitor

  2026-07-14

  Ridaforolimus (Deforolimus, MK-8669) is a highly potent and selective mTOR pathway inhibitor with nanomolar efficacy. It demonstrates robust antiproliferative and anti-angiogenic activity across diverse cancer cell lines and models. APExBIO supplies validated Ridaforolimus for advanced cancer and senescence research.

• EZ Cap™ Human PTEN mRNA (ψUTP): Beyond Stability—Enabling Fu

  2026-07-14

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP), a cutting-edge in vitro transcribed mRNA, empowers advanced cancer research with robust mRNA stability and potent PI3K/Akt pathway inhibition. This article uniquely examines its mechanistic depth, translational considerations, and practical assay guidance.

• Synergistic CDK4/6 and BET Inhibition in Pancreatic Cancer

  2026-07-13

  Gu et al. (2025) demonstrate that combined CDK4/6 and BET inhibition synergistically suppresses pancreatic ductal adenocarcinoma growth and reverses pro-metastatic phenotypes by modulating the GSK3β-mediated Wnt/β-catenin pathway. This mechanistic insight supports rational combination strategies for overcoming therapeutic resistance in pancreatic cancer.

• a-MSH, amide: Innovating Translational Pigmentation Research

  2026-07-13

  This thought-leadership article provides mechanistic insight and strategic guidance for translational researchers using a-MSH, amide in pigmentation regulation and anti-inflammatory studies. Integrating recent evidence on melanogenesis modulation, it contextualizes APExBIO’s a-MSH, amide within the evolving landscape, highlights protocol best practices, and charts a visionary path for translational impact.

• Live-Dead Cell Staining Kit: Precision Cell Viability in Act

  2026-07-12

  Unlock rigorous, quantitative live/dead cell analysis across cytotoxicity, biomaterial, and wound-healing research. The Live-Dead Cell Staining Kit leverages dual-dye discrimination for unmatched accuracy in both microscopy and flow cytometry workflows.

• ATRX Deficiency Sensitizes Glioma Cells to RTK and PDGFR Inh

  2026-07-10

  This study reveals that high-grade glioma cells lacking ATRX are significantly more sensitive to multi-targeted receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors. These findings highlight the importance of considering ATRX mutation status when designing targeted therapeutic strategies and analyzing clinical trial outcomes in glioma.

• Quercetin Shields Cataract Lenses by Modulating Hippo Pathwa

  2026-07-09

  The referenced study uncovers how quercetin exerts protective effects against cataract formation by downregulating the Hippo signaling pathway, thereby enhancing epithelial cell survival and reducing oxidative stress. These findings provide mechanistic insight for non-surgical cataract interventions and highlight the potential for pathway-targeted therapies.

• Phosphoenolpyruvate Restricts cGAS-STING Inflammation in Agi

  2026-07-09

  The referenced study uncovers a conserved, adaptive role for the glycolytic metabolite phosphoenolpyruvate (PEP) in repressing cGAS-STING-mediated inflammation during aging. These findings provide a mechanistic basis for targeting metabolic signaling to promote healthy aging and suggest new avenues for metabolic probe use in inflammation and energy homeostasis research.

8148 records 5/544 page Previous Next 12345 下5页 Last page